United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. A biotechnology company in Research Triangle Park has taken a major step to develop a new option for ...

United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. STORY HIGHLIGHTS FDA clears United Therapeutics for human trials of pig-to-human kidney transplants.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Feb. 07, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq ... today announced the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 04, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced full enrollment of the TETON 1 study ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

--(BUSINESS WIRE)--Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company ... Completion of the transaction is expected in the first half of 2025, pending the expiration of ...

Total operating revenues for the full year 2023 were $16.3M ... ByInvesting.com • Mar 13, 2024 Ryvu Therapeutics Announces Disbursement of First Tranche of EUR 8 Million Venture Debt from ...

Researchers at E-Therapeutics plc recently presented efficacy and safety data on ETX-148, a pan-hemophilia agent in murine models of hemophilia A and B.